Genpharmasec Financial Results
Genpharmasec approved unaudited half-year results and planned sale of its wholly owned subsidiary Clinigenome India. Company Secretary Hardik Makwana resigns effective 16 November 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Genpharmasec approved unaudited half-year results and planned sale of its wholly owned subsidiary Clinigenome India. Company Secretary Hardik Makwana resigns effective 16 November 2026.
Genpharmasec Ltd reported revenue from operations of ₹49.7 Cr (+314.2% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
Genpharmasec Ltd reported revenue from operations of ₹55.4 Cr (+295.7% YoY) and net profit of ₹1.4 Cr for Q4 FY26.
Genpharmasec Limited reported its audited standalone and consolidated financial results for fiscal year 2026. The board also re-appointed M/s. Abhishek M Agrawal & Co. as internal auditors.